AACR24
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
AACR24
May 4, 2024, 16:54 |
Insight
Elizabeth McKenna: The May issue of Cancer Discovery
Elizabeth McKenna shared on LinkedIn: "The May issue of Cancer Discovery is now online! The…
Apr 26, 2024, 09:41 |
Blog
Vivek Subbiah: Read a recap of 'AI at the Interface' at AACR24 plenary session in AACR Annual Meeting News
Vivek Subbiah posted on X/Twitter: ''Yes! The future IS now! 'AI at the Interface: Accelerating…
Apr 25, 2024, 18:50 |
Insight
Wafik S. El-Deiry: Very pleased to share bioRxiv pre-print by El-Deiry Lab member and Brown University alumnus William MacDonald
Wafik S. El-Deiry, Director of the Legorreta Cancer Center at Brown University, shared on X:…
Apr 23, 2024, 21:38 |
Blog
Mia Levy: Great discussion about the need for rigorous clinical validation for new AI tools
Mia Levy, Chief Medical Officer at Foundation Medicine, shared on LinkedIn: "I enjoyed joining Vivek…
Apr 23, 2024, 10:07 |
Insight
Ashley Magargee: Fortunate to have leading computational biology experts like Aviv Regev advancing our understanding of cancer like never before
Ashley Magargee, Chief Executive Officer at Genentech, shared on LinkedIn: "We’re fortunate to have leading…
Apr 21, 2024, 06:04 |
Blog
Libia F. Scheller: Participating in a 5K run at the AACR conference to raise funds for cancer research is nothing short of a blessing
Libia F. Scheller, Global Head of Oncology- Cooperative Groups and Strategic Alliances at Bayer HealthCare, shared…
Apr 18, 2024, 17:21 |
Insight
The 2023 impact report by Conquer Cancer, the ASCO Foundation
Conquer Cancer, the ASCO Foundation, shared on Linkedin: “Last year, your gifts supported the brightest minds…
Apr 17, 2024, 17:23 |
Blog
Vivek Subbiah: Should we consider them 2nd generation PARP inhibitors or a completely NEW class of drugs?
Vivek Subbiah shared a post on X: "More than a dozen PARP1 selective drugs in different…
Apr 16, 2024, 12:00 |
Blog
Daniel De Carvalho: It was an honour to chair the early cancer biology plenary session this year at AACR annual meeting
Daniel De Carvalho, Co-founder and Chief Scientific Officer at Adela and Professor at Princess Margaret…
Apr 15, 2024, 21:00 |
Blog
On the dangers of blood clots for people with cancer and what patients can do to lower their risk - AACR
American Association for Cancer Research shared on LinkedIn: "Oncologist Michael B. Streiff on the dangers of…
1
2
3
4
5
All:
128
Posts:
1 - 10
Neuroendocrine tumors - newly updated AJCC guidelines
5 min Sarcoma Talk with Shushan Hovsepyan and Andrea Ferrari
OncoInfluencers: Dialogue with Tony Mok, hosted by Gevorg Tamamyan
New Paper Alert! Complete Response with Chemoimmunotherapy in Intrahepatic Cholangiocarcinoma
Vincent Rajkumar on the Importance of Accelerated Approval for Cancer Treatment
Facebook
RSS Feed
Twitter
Linkedin
Youtube